Is TVTX stock safe? | Glauxie AI

Q: Is TVTX stock safe?

Travere Therapeutics, Inc. (TVTX) operates in the Biotechnology industry (Healthcare sector). The company is led by CEO Eric Dube. Travere Therapeutics, Inc., a biopharmaceutical company, focuses on the identification, development, commercialization, and delivering of therapies for the treatment of rare diseases. Its marketed... Employees: 497.

Q: What are the risks of investing in TVTX?

Identify key risks of investing in TVTX — debt, competition, volatility, and sector headwinds.

Q: Is TVTX a good long-term investment?

Evaluate TVTX as a long-term investment using fundamental scores, growth metrics, and risk assessment.

Q: How much debt does TVTX have?

Review TVTX total debt, debt-to-equity ratio, interest coverage, and leverage trends.

Is TVTX stock safe?

🦉

Travere Therapeutics, Inc. (TVTX)

Company Overview

Sector / IndustryHealthcare / Biotechnology

CEOEric Dube

Travere Therapeutics, Inc., a biopharmaceutical company, focuses on the identification, development, commercialization, and delivering of therapies for the treatment of rare diseases. Its marketed products include Chenodal, a synthetic oral form of chenodeoxycholic acid for the treatment of...

Key Executives

Name	Title
Angela Giannantonio	Chief People Officer
Casey Logan	Chief Business Officer
Charlotte Smith	Chief Corporate Affairs Officer
Christopher Cline	Chief Financial Officer
Elizabeth E. Reed	Chief Legal Officer, General Counsel & Secretary
Eric Dube	President, Chief Executive Officer & Director

Financial Health

Risk Assessment

Weather Score0/100

RegimeN/A

TVTX Profile Financials

What are the risks of investing in TVTX? Is TVTX a good long-term investment? How much debt does TVTX have?